FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1036613081> ?p ?o ?g. }

• W1036613081 abstract "Neoadjuvant chemotherapy (NACT) is an accepted treatment approach in early-stage breast cancer. In contrast, the potential role of postneoadjuvant chemotherapy after taxane-containing NACT remains unclear. The aim of this study was to evaluate postneoadjuvant chemotherapy and further prognostic factors that predict outcome in women without pathologic complete remission (pCR).A total of 377 patients with breast cancer who received preoperative chemotherapy were included in this retrospective study. Patients without standard NACT (6 cycles of epirubicin with docetaxel) or primary metastatic breast cancer and locally advanced, inoperable cancer were excluded from further analysis (n = 186). This resulted in a study population of 191 women (30 [15.7%] with pCR; 161 [84.3%] without pCR). Major outcome parameters were event-free survival (EFS) and overall survival (OS). The following parameters were tested for their prognostic role: postneoadjuvant chemotherapy, patient age, breast cancer subtype (luminal/HER2-negative tumors, HER2-positive tumors, and triple-negative tumors), histological grade, pCR, residual lymph node invasion, and residual invasive tumor size.At a median follow-up of 54 months, 51 disease relapses (26.7%) and 21 deaths (11%) were observed. In a comparison of patients with pCR with those without, no significant differences in EFS or OS were observed. Postneoadjuvant chemotherapy was significantly associated with shorter OS in patients without pCR.In this population, which included a high percentage of patients with luminal cancers, pCR did not predict for improved OS. Postneoadjuvant chemotherapy showed no discernible benefit even in subgroups with aggressive tumor biology or significant remaining tumor burden. The use of such treatment should therefore be discouraged outside of clinical trials." @default.
• W1036613081 created "2016-06-24" @default.
• W1036613081 creator A5000827523 @default.
• W1036613081 creator A5001256203 @default.
• W1036613081 creator A5005412089 @default.
• W1036613081 creator A5006583038 @default.
• W1036613081 creator A5015052494 @default.
• W1036613081 creator A5017092675 @default.
• W1036613081 creator A5041466806 @default.
• W1036613081 creator A5042560676 @default.
• W1036613081 creator A5042865176 @default.
• W1036613081 creator A5046420883 @default.
• W1036613081 creator A5055465009 @default.
• W1036613081 creator A5062590114 @default.
• W1036613081 creator A5066101417 @default.
• W1036613081 creator A5068091207 @default.
• W1036613081 creator A5076784790 @default.
• W1036613081 date "2015-12-01" @default.
• W1036613081 modified "2023-10-05" @default.
• W1036613081 title "Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy" @default.
• W1036613081 cites W1992353084 @default.
• W1036613081 cites W2003303180 @default.
• W1036613081 cites W2004678546 @default.
• W1036613081 cites W2029325271 @default.
• W1036613081 cites W2030892258 @default.
• W1036613081 cites W2058725220 @default.
• W1036613081 cites W2075894019 @default.
• W1036613081 cites W2096864872 @default.
• W1036613081 cites W2107602135 @default.
• W1036613081 cites W2110934536 @default.
• W1036613081 cites W2114264989 @default.
• W1036613081 cites W2117775530 @default.
• W1036613081 cites W2118804515 @default.
• W1036613081 cites W2132893003 @default.
• W1036613081 cites W2147415463 @default.
• W1036613081 cites W2155803397 @default.
• W1036613081 doi "https://doi.org/10.1016/j.clbc.2015.06.007" @default.
• W1036613081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26195436" @default.
• W1036613081 hasPublicationYear "2015" @default.
• W1036613081 type Work @default.
• W1036613081 sameAs 1036613081 @default.
• W1036613081 citedByCount "4" @default.
• W1036613081 countsByYear W10366130812018 @default.
• W1036613081 countsByYear W10366130812019 @default.
• W1036613081 countsByYear W10366130812020 @default.
• W1036613081 crossrefType "journal-article" @default.
• W1036613081 hasAuthorship W1036613081A5000827523 @default.
• W1036613081 hasAuthorship W1036613081A5001256203 @default.
• W1036613081 hasAuthorship W1036613081A5005412089 @default.
• W1036613081 hasAuthorship W1036613081A5006583038 @default.
• W1036613081 hasAuthorship W1036613081A5015052494 @default.
• W1036613081 hasAuthorship W1036613081A5017092675 @default.
• W1036613081 hasAuthorship W1036613081A5041466806 @default.
• W1036613081 hasAuthorship W1036613081A5042560676 @default.
• W1036613081 hasAuthorship W1036613081A5042865176 @default.
• W1036613081 hasAuthorship W1036613081A5046420883 @default.
• W1036613081 hasAuthorship W1036613081A5055465009 @default.
• W1036613081 hasAuthorship W1036613081A5062590114 @default.
• W1036613081 hasAuthorship W1036613081A5066101417 @default.
• W1036613081 hasAuthorship W1036613081A5068091207 @default.
• W1036613081 hasAuthorship W1036613081A5076784790 @default.
• W1036613081 hasConcept C121608353 @default.
• W1036613081 hasConcept C126322002 @default.
• W1036613081 hasConcept C143998085 @default.
• W1036613081 hasConcept C2776694085 @default.
• W1036613081 hasConcept C2776802502 @default.
• W1036613081 hasConcept C2777511904 @default.
• W1036613081 hasConcept C2779786085 @default.
• W1036613081 hasConcept C2780835546 @default.
• W1036613081 hasConcept C2781190966 @default.
• W1036613081 hasConcept C2908647359 @default.
• W1036613081 hasConcept C530470458 @default.
• W1036613081 hasConcept C71924100 @default.
• W1036613081 hasConcept C99454951 @default.
• W1036613081 hasConceptScore W1036613081C121608353 @default.
• W1036613081 hasConceptScore W1036613081C126322002 @default.
• W1036613081 hasConceptScore W1036613081C143998085 @default.
• W1036613081 hasConceptScore W1036613081C2776694085 @default.
• W1036613081 hasConceptScore W1036613081C2776802502 @default.
• W1036613081 hasConceptScore W1036613081C2777511904 @default.
• W1036613081 hasConceptScore W1036613081C2779786085 @default.
• W1036613081 hasConceptScore W1036613081C2780835546 @default.
• W1036613081 hasConceptScore W1036613081C2781190966 @default.
• W1036613081 hasConceptScore W1036613081C2908647359 @default.
• W1036613081 hasConceptScore W1036613081C530470458 @default.
• W1036613081 hasConceptScore W1036613081C71924100 @default.
• W1036613081 hasConceptScore W1036613081C99454951 @default.
• W1036613081 hasLocation W10366130811 @default.
• W1036613081 hasLocation W10366130812 @default.
• W1036613081 hasOpenAccess W1036613081 @default.
• W1036613081 hasPrimaryLocation W10366130811 @default.
• W1036613081 hasRelatedWork W1971716849 @default.
• W1036613081 hasRelatedWork W1998612051 @default.
• W1036613081 hasRelatedWork W2013223170 @default.
• W1036613081 hasRelatedWork W2014205823 @default.
• W1036613081 hasRelatedWork W2018426258 @default.
• W1036613081 hasRelatedWork W2081101257 @default.
• W1036613081 hasRelatedWork W2085844047 @default.
• W1036613081 hasRelatedWork W2143637725 @default.
• W1036613081 hasRelatedWork W2148330678 @default.

• next